Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2025-12-24 @ 2:32 PM
NCT ID:
NCT00003159
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically proven non-small cell lung cancer
* Resectable disease
* Previously untreated disease
* No evidence of distant metastases
PATIENT CHARACTERISTICS:
Age:
* Any age
Performance status:
* WHO 0-2
Life expectancy:
* Not specified
Hematopoietic:
* WBC greater than 3,000/mm\^3
* Neutrophil count greater than 1,500/mm\^3
* Platelet count greater than 100,000/mm\^3
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* Considered fit for chemotherapy and surgical resection
* No other disease or prior malignancy that would preclude study treatment
* No active infection
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* No concurrent prophylactic colony-stimulating factors (except for secondary prophylaxis)
* No concurrent immunotherapy
Chemotherapy:
* Not specified
Endocrine therapy:
* No concurrent hormonal agents, except corticosteroids
Radiotherapy:
* Not specified
Surgery:
* Not specified
Other:
* No other concurrent anticancer therapy
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00003159
Study Brief:
Protocol Section:
NCT00003159